Oestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms
Open Access
- 1 December 1994
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 70 (6) , 1095-1101
- https://doi.org/10.1038/bjc.1994.454
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor.1992
- Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitroEuropean Journal Of Cancer, 1992
- DIFFERENTIAL-EFFECTS OF PHORBOL ESTER ON EPIDERMAL GROWTH-FACTOR RECEPTORS IN ESTROGEN RECEPTOR-POSITIVE AND RECEPTOR-NEGATIVE BREAST-CANCER CELL-LINES1990
- STRUCTURE AND INDUCIBLE REGULATION OF THE HUMAN C-ERB B2/NEU PROMOTER1990
- PROTO-ONCOGENE AMPLIFICATION AND HUMAN-BREAST TUMOR PHENOTYPE1989
- HETEROGENEOUS EXPRESSION OF ERBB-2 MESSENGER-RNA IN HUMAN-BREAST CANCER1989
- Expression of the c‐erbB‐2 protein in normal and transformed cellsInternational Journal of Cancer, 1987
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation.Molecular and Cellular Biology, 1987
- Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.Proceedings of the National Academy of Sciences, 1983